Financial Year |
March 31 2023 |
Monetary Funds |
334,185,238.07 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
7,680,811.40 |
Accounts Receivable |
392,731,683.05 |
Advances to Suppliers |
85,752,247.36 |
Other Receivables |
3,919,737.56 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
316,102,153.81 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
28,107,465.64 |
Total Current Assets |
1,219,595,746.11 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
19,538,289.29 |
Investment Properties |
-- |
Fixed Assetes |
354,989,830.41 |
Under-construction Projects |
476,800,507.38 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
99,271,166.27 |
R&D expenses |
56,732,567.91 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,199,121.67 |
Deferred Income Tax Assets |
5,609,346.58 |
Other Non-Current Assets |
114,742,049.31 |
Sub-Total of Non-Current Assets |
1,133,382,424.76 |
Total Assets |
2,352,978,170.87 |
Short-Term Loans |
418,286,060.53 |
Trading Financial liabilities |
-- |
Notes Payable |
36,087,830.03 |
Accounts Payable |
210,002,902.56 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
16,211,189.17 |
Taxes Payable |
27,941,323.86 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
34,118,591.67 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
4,779,847.62 |
Other Current Liabilities |
13,981,731.68 |
Sub-Total of Current Liabilities |
868,961,259.33 |
Long-term Loans |
367,328,575.39 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
428,329,185.76 |
Total Liabilities |
1,297,290,445.09 |
Paid-In Capital(Or Share Stock) |
400,108,752.00 |
Capital Surplus |
290,564,747.73 |
Surplus Reserve |
57,736,340.45 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
306,038,059.93 |
Minority Stockholder's Interest |
1,239,825.67 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,054,447,900.11 |
Owner's Equity(Stockholder's Equity) |
1,055,687,725.78 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,352,978,170.87 |